Periscope Capital’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Periscope Capital’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-572,400	Closed	-$47.2K	–	770
2023 Q1	$47.2K	Hold	572,400	–	–	﹤0.01%	545
2022 Q4	$2.92K	Buy	572,400 +142,404	+33%	+$7.01K	﹤0.01%	869
2022 Q3	$51K	Buy	429,996 +229,096	+114%	+$40.2K	﹤0.01%	700
2022 Q2	$21K	Hold	200,900	–	–	﹤0.01%	939
2022 Q1	$70K	Buy	+200,900	New	+$81.4K	﹤0.01%	856

Periscope Capital's LVACW Position: Q2 2023 in Review

Periscope Capital sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 572,400 shares — an estimated $47.2K sold.

Periscope Capital first reported a position in LVACW in Q1 2022 and held it in 5 quarters. The position peaked at $70K in Q1 2022. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Periscope Capital reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Periscope Capital sold 572,400 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $47.2K.
Periscope Capital first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q1 2022 and held it in 5 quarters.
Periscope Capital's LAVA Medtech Acquisition Corp. Warrants position peaked at $70K in Q1 2022.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Periscope Capital's 13F filing for Q2 2023, filed 14 Aug 2023.